2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04391361 (ClinicalTrials.gov)	November 1, 2020	13/5/2020	The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS	The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of Amyotrophic L ...	Amyotrophic Lateral Sclerosis;Respiratory Function;Scopolamine	Drug: Scopolamine , atropine, edaravone and dexmedetomidine;Drug: Edaravone	Ruijin Hospital	NULL	Not yet recruiting	30 Years	65 Years	All	30	Phase 2	China
2	EUCTR2018-000142-18-FI (EUCTR)	09/05/2018	08/05/2018	Feasibility and effects of subcutaneously given combination of dexmedetomidineand ketamine in ALS pa ...	Feasibility and pharmacodynamics of subcutaneously given combination of dexmedetomidineand ketamine ...	Amyotrophic lateral sclerosis (ALS) MedDRA version: 20.1;Level: LLT;Classification code 10036704;Ter ...	Trade Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Trade Name: Ketanest -S INN or Proposed INN: ESK ...	Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Finland

First Previous1Next Last